Authors: BANNERJI R ARROYO CD CORDONCARDO C GILBOA E

Citation: R. Bannerji et al., THE ROLE OF IL-2 SECRETED FROM GENETICALLY-MODIFIED TUMOR-CELLS IN THE ESTABLISHMENT OF ANTITUMOR IMMUNITY, The Journal of immunology, 152(5), 1994, pp. 2324-2332

Authors: VIEWEG J ROSENTHAL FM BANNERJI R HESTON WDW FAIR WR GANSBACHER B GILBOA E

Citation: J. Vieweg et al., IMMUNOTHERAPY OF PROSTATE-CANCER IN THE DUNNING RAT MODEL - USE OF CYTOKINE GENE MODIFIED TUMOR VACCINES, Cancer research, 54(7), 1994, pp. 1760-1765

Authors: SAITO S BANNERJI R GANSBACHER B ROSENTHAL FM ROMANENKO P HESTON WDW FAIR WR GILBOA E

Citation: S. Saito et al., IMMUNOTHERAPY OF BLADDER-CANCER WITH CYTOKINE GENE-MODIFIED TUMOR VACCINES, Cancer research, 54(13), 1994, pp. 3516-3520

Authors: ROSENTHAL FM CRONIN K BANNERJI R GOLDE DW GANSBACHER B

Citation: Fm. Rosenthal et al., AUGMENTATION OF ANTITUMOR IMMUNITY BY TUMOR-CELLS TRANSDUCED WITH A RETROVIRAL VECTOR CARRYING THE INTERLEUKIN-2 AND INTERFERON-GAMMA CDNAS, Blood, 83(5), 1994, pp. 1289-1298

Authors: CONNOR J BANNERJI R SAITO S HESTON W FAIR W GILBOA E

Citation: J. Connor et al., REGRESSION OF BLADDER-TUMORS IN MICE TREATED WITH INTERLEUKIN-2 GENE-MODIFIED TUMOR-CELLS (VOL 177, PG 1127, 1993), The Journal of experimental medicine, 177(6), 1993, pp. 1833-1833